Equilis Te (pack of 10)-Hyperdrug

Presentation Suspension for injection containing purified Tetanus Toxoid (40Lf* per dose). 375 ug Purified Saponin, 125 µg Cholesterol and 62.5 µg Phosphatidycholine are added as adjuvants. Traces of Thiomersal are present. * Flocculation equivalents; corresponds with ≥ 30 IU/ml guinea pig serum in the Ph.Eur. potency test Uses Active immunisation of horses from 6 months of age against tetanus to prevent mortality. Onset of immunity: 2 weeks after the primary vaccination course. Duration of immunity: 17 months after the primary vaccination course, 24 months after the first revaccination.

Dosage and administration Vaccination schedule: Primary vaccination course Administer one dose (1ml), by intramuscular injection, according to the following schedule: Primary vaccination course: first injection from 6 months of age, second injection 4 weeks later. Revaccination:The first revaccination is given not later than 17 months after the basic vaccination course. Thereafter a maximum interval of two years is recommended In case of increased infection risk or insufficient colostrum intake, an additional initial injection can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 6 months of age and 4 weeks later). Concurrent active and passive immunisation (emergency vaccination) The vaccine can be used together with Tetanus antitoxin Behring for treatment of injured horses that have not been immunised against tetanus. In that case, the first dose (V1) of vaccine can be given concurrently with the appropriate prophylactic dose of Tetanus Antitoxin Behring at a separate injection site, using separate syringes and needles. This will lead to a passive protection against tetanus for at least 21 days after concurrent administration. The second dose of the vaccine (V2) should be administered 4 weeks later. A third vaccination with Equilis Te should be repeated at least four weeks later. Concurrent use of Equilis Te and Tetanus Antitoxin Behring may reduce active immunity against tetanus compared to horses vaccinated with Equilis Te in the absence of tetanus antitoxin serum. Can be used during pregnancy and lactation.

Contra-indications, warnings, etc A diffuse hard or soft swelling (max. diameter 5 cm) may occur, regressing within 2 days. Pain at the injection site can occur occasionally. In some cases fever may occur for 1 day, and up to 3 days in exceptional circumstances. Following the administration of a double dose of vaccine, no side-effects other than those described above have been observed except for some depression at the day of vaccination. Only healthy animals should be vaccinated. Safety and efficacy data are available which demonstrate that this vaccine can be administered on the same day but not mixed with Tetanus Antitoxin Behring. No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the product mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis. Do not mix with any other veterinary medicinal product. Foals should not be vaccinated before the age of 6 months, especially when born to mares that were revaccinated in the last two months of gestation, because of possible interference by maternally derived antibodies. Operator warning: In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Withdrawal periods: Zero days For animal treatment only. Keep out of the reach and sight of children. Pharmaceutical precautions Store at 2° to 8°C. Protect from light. Do not freeze. Disposal advice: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.